Clinical trial
Aromatase Inhibitor Clinical Trial
NCT00228956 · National Institute of General Medical Sciences (NIGMS), NIH · Unknown status
Key facts
| NCT number | NCT00228956 |
|---|---|
| Title | Aromatase Inhibitor Clinical Trial |
| Official title | A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism |
| Lead sponsor | National Institute of General Medical Sciences (NIGMS), NIH |
| Collaborators | Indiana University School of Medicine Office of Research on Women's Health (ORWH) NIH National Institute of Environmental Health Sciences (NIEHS) |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | pharmacodynamic analysis |
| Enrollment | 500 |
| Start date | Jan 1, 2005 |
| Completion | Feb 1, 2009 |
| First posted | Sep 29, 2005 |
| Last update posted | Sep 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: